2372-2302 Screening compound: 3,5-diacetamido-N-{4-[(1E)-3-oxo-3-phenylprop-1-en-1-yl]phenyl}benzamide

2372-2302 Screening compound: 3,5-diacetamido-N-{4-[(1E)-3-oxo-3-phenylprop-1-en-1-yl]phenyl}benzamide
2372-2302 Screening compound: 3,5-diacetamido-N-{4-[(1E)-3-oxo-3-phenylprop-1-en-1-yl]phenyl}benzamide alternative view

Chemical Structure Depiction of ChemDiv screening compound 2372-2302
3,5-diacetamido-N-{4-[(1E)-3-oxo-3-phenylprop-1-en-1-yl]phenyl}benzamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

2372-2302

Molecular Formula

C26H23N3O4 (C26 H23 N3 O4)

Compound Name

3,5-diacetamido-N-{4-[(1E)-3-oxo-3-phenylprop-1-en-1-yl]phenyl}benzamide

IUPAC name

35-diacetamido-N-{4-[(1E)-3-oxo-3-phenylprop-1-en-1-yl]phenyl}benzamide

SMILES

CC(Nc1cc(C(Nc2ccc(/C=C/C(c3ccccc3)=O)cc2)=O)cc(NC(C)=O)c1)=O

InChI

InChI=1S/C26H23N3O4/c1-17(30)27-23-14-21(15-24(16-23)28-18(2)31)26(33)29-22-11-8-19(9-12-22)10-13-25(32)20-6-4-3-5-7-20/h3-16H,1-2H3,(H,27,30)(H,28,31)(H,29,33)

InChI Key

BZVRJQJGTUBRPH-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD00316848

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

441.49

Hydrogen Bond Acceptors Count

8.00

Hydrogen Bond Donors Count

3.00

Rotatable Bond Count

10.00

Number of Nitrogen and Oxygen Atoms

7

Partition Coefficient, logP

3.687

Distribution Coefficient, logD

3.686

Water Solubility, LogSw

-4.09

Polar Surface Area

82.829

Acid Dissociation Constant (pKa)

10.28

Base Dissociation Constant (pKb)

-1.25

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

7.70

2372-2302 in Drug Discovery

Included in Screening Libraries

Antimitotic Tubulin Library (17355 compounds)

KRAS-Targeted Library (16000 compounds)

?ysteine Targeted Covalent Library (39471 compounds)

Histone Deacetylases (HDAC) Targeted Library (9760 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Digestive system
  • Respiratory tract
  • Otorhinolaryngologic
  • Male
  • Female
  • Hemic and lymphatic
  • Skin
  • Cancer
  • Digestive system
  • Respiratory tract
  • Otorhinolaryngologic
  • Cancer
  • Nervous system
  • Hemic and lymphatic
  • Endocrine
  • Immune system
Targets:
  • Kinases
Mechanism of action:
  • Epigenetic

References: we are preparing a list of scientific research reports with 2372-2302 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound 2372-2302?
Check Price and Availability of 2372-2302, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of 2372-2302 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for 2372-2302
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for 2372-2302
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of 2372-2302 available by request